• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Rydex Inverse 2x S&P MidCap 400

Rydex Inverse 2x S&P MidCap 400

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. TREATY Energy Corporation Announces Update and Vision Statement

    TREATY Energy Corporation Announces Update and Vision Statement

  2. Research and Markets: Relapsing Multiple Sclerosis (RMS ) Global Clinical Trials Review, H2, 2014

    Research and Markets: Relapsing Multiple Sclerosis ( RMS ) Global Clinical Trials Review, H2, 2014

  3. Global Ebola Pandemic Unlikely, Say Catastrophe Risk Management Experts

    Global Ebola Pandemic Unlikely, Say Catastrophe Risk Management Experts

  4. Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis

    Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.